James R. Tobin, Director at TransMedics Group, Inc. (TMDX), sold 20,136 shares at $32.80 ($661K) on 2021-02-09, disclosed to the SEC on 2021-02-10.
Open-market sale of $661k TMDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.80 | 9,968 | $327K | 49.5% |
| 2 | $32.80 | 9,968 | $327K | 49.5% |
| 3 | $34.18 | 200 | $7K | 1.0% |
| Total | $32.81 avg | 20,136 | $661K | 100% |
| Filing → |
| TMDX | SELL | 2024-05-03 | $3.0M | — | Filing → |
| TMDX | SELL | 2024-03-05 | $2.2M | — | Filing → |
| TMDX | SELL | 2023-11-29 | $701K | — | Filing → |